{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhang M"],"funding":["Innovation-Driven Project of Central South University","China Postdoctoral Science Foundation Funded Project","Project of scientific research plan of hunan provincial health commission","National Natural Science Foundation of China","Outstanding Youth Fund of Natural Science Foundation of Hunan Province"],"pagination":["7213"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11871002"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(1)"],"pubmed_abstract":["Lung cancer is prevalent worldwide and is a major cause of cancer-related mortality. Despite being the primary model for immunotherapy research, the response rates of lung cancer patients to immunotherapy are unsatisfactory. Furthermore, research on immunogenic cell death (ICD) in lung cancer is limited, which limits the development of strategies that combine ICD-related therapies with immunotherapy. In this study, we compiled and summarized 69 genes associated with ICD and developed an IRS. Across seven independent datasets, the IRS was identified as an independent prognostic factor. IRS was positively associated with multiple tumor proliferation pathways and negatively associated with immune-related pathways. Additionally, IRS negatively correlated with the infiltration of various immune"],"journal":["Scientific reports"],"pubmed_title":["Immunogenic cell death signature predicts survival and reveals the role of VEGFA + Mast cells in lung adenocarcinoma."],"pmcid":["PMC11871002"],"funding_grant_id":["2021M693558","2020CX043","82273215","2021JJ20092","202204022468"],"pubmed_authors":["Zhang G","Wei B","Chang R","Liu Q","Zhang M","Zhou G","Xu Y"],"additional_accession":[]},"is_claimable":false,"name":"Immunogenic cell death signature predicts survival and reveals the role of VEGFA + Mast cells in lung adenocarcinoma.","description":"Lung cancer is prevalent worldwide and is a major cause of cancer-related mortality. Despite being the primary model for immunotherapy research, the response rates of lung cancer patients to immunotherapy are unsatisfactory. Furthermore, research on immunogenic cell death (ICD) in lung cancer is limited, which limits the development of strategies that combine ICD-related therapies with immunotherapy. In this study, we compiled and summarized 69 genes associated with ICD and developed an IRS. Across seven independent datasets, the IRS was identified as an independent prognostic factor. IRS was positively associated with multiple tumor proliferation pathways and negatively associated with immune-related pathways. Additionally, IRS negatively correlated with the infiltration of various immune","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Feb","modification":"2026-06-01T11:14:16.904Z","creation":"2025-04-07T11:26:56.508Z"},"accession":"S-EPMC11871002","cross_references":{"pubmed":["40021802"],"doi":["10.1038/s41598-025-91401-5"]}}